Denali Therapeutics Inc. Common Stock
DNLI
Jodie situation report
Denali Therapeutics Inc. Common Stock's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 22 directly disclosed connections are confirming.
- Track Takeda’s stated termination status, any amendments, and any disclosed payments, obligations, or retained rights under the DNL593 collaboration agreement.
Invalidation: The isolated read changes if DNLI's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind DNLI
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BIIBBiogen Inc.partnerMay 7, 2026 ▾
“PGRN levels in the brain with the goal of treating frontotemporal dementia ("FTD") associated with a mutation in the granulin ("GRN") gene and is being developed in collaboration with Takeda; • BIIB122/DNL151, a small molecule LRRK2 inhibitor, is being develo…”
SNYSanofipartnerMay 7, 2026 ▾
“For programs covered by collaboration agreements (including those with Takeda, Sanofi, and Biogen), we expect to commercialize only in certain geographies, as defined by the terms of the agreements with the counterpart, and rely on our partners to provide com…”
Depended on by
BIIBBiogen Inc.investeeApr 29, 2026 ▾
“The net unrealized gains recognized during the three months ended March 31, 2026, primarily reflect an increase in the aggregate fair value of our investment in Denali common stock of approximately $19.2 million.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 19 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
DNLI is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.